Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Rating of “Hold” by Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has earned an average recommendation of “Hold” from the eighteen brokerages that are currently covering the company, MarketBeat.com reports. Eleven analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $11.26.

A number of research analysts recently commented on the company. The Goldman Sachs Group reduced their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a report on Monday, March 3rd. Piper Sandler decreased their price target on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Royal Bank of Canada increased their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, Oppenheimer dropped their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th.

Teladoc Health Trading Up 3.1 %

NYSE TDOC opened at $8.43 on Tuesday. The stock has a market cap of $1.46 billion, a P/E ratio of -1.46 and a beta of 1.27. The company’s fifty day simple moving average is $10.42 and its 200-day simple moving average is $9.75. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $15.43.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Equities research analysts predict that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. grew its holdings in Teladoc Health by 15.5% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock worth $15,617,000 after buying an additional 228,004 shares in the last quarter. Jennison Associates LLC acquired a new position in Teladoc Health during the 3rd quarter worth $1,544,000. Massachusetts Financial Services Co. MA grew its stake in shares of Teladoc Health by 477.1% in the third quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider’s stock worth $3,397,000 after purchasing an additional 305,961 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Teladoc Health by 1.5% during the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after purchasing an additional 56,864 shares during the period. Finally, Maple Rock Capital Partners Inc. bought a new stake in shares of Teladoc Health during the third quarter valued at about $11,291,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.